z-logo
open-access-imgOpen Access
Differential Requirements for Protection against Mucosal Challenge withFrancisella tularensisin the Presence versus Absence of Cholera Toxin B and InactivatedF. tularensis
Author(s) -
Constantine Bitsaktsis,
Deepak B. Rawool,
Ying Li,
N.V. Kurkure,
Bibiana V. Iglesias,
Edmund J. Gosselin
Publication year - 2009
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.0803242
Subject(s) - francisella tularensis , tularemia , microbiology and biotechnology , cholera toxin , biology , immunity , humoral immunity , immunization , immune system , vibrio cholerae , virology , cholera , immunology , bacteria , virulence , biochemistry , genetics , gene
Francisella tularensis is a category A biothreat agent for which there is no approved vaccine and the correlates of protection are not well understood. In particular, the relationship between the humoral and cellular immune response to F. tularensis and the relative importance of each in protection is controversial. Yet, understanding this relationship will be crucial to the development of an effective vaccine against this organism. We demonstrate, for the first time, a differential requirement for humoral vs cellular immunity in vaccine-induced protection against F. tularensis infection, and that the requirement for Ab observed in some protection studies, may be overcome through the induction of enhanced cellular immunity. Specifically, following intranasal/mucosal immunization of mice with inactivated F. tularensis organisms plus the cholera toxin B subunit, we observe increased production of IgG2a/2c vs IgG1 Ab, as well as IFN-gamma, indicating induction of a Th1 response. In addition, the requirement for F. tularensis-specific IgA Ab production, observed in studies following immunization with inactivated F. tularensis alone, is eliminated. Thus, these data indicate that enhanced Th1 responses can supersede the requirement for anti-F. tularensis-specific IgA. This observation also has important ramifications for vaccine development against this organism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom